Otherside Farms

JANUARY 24, 2019

Federal regulators have approved two clinical studies testing whether a marijuana-based epilepsy drug may help prevent seizures among epileptic children. Although both studies will enroll 25 patients initially, the U.S. Source: FDA Approves Marijuana-Based Epilepsy Drug For Use On Kids In Clinical Trials. In the upcoming U.S.

Clinical Trials 45

Clinical Trials Epilepsy Marijuana Pharmaceutical 45

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

LifeCannMD

JANUARY 2, 2024

Here’s a breakdown of how cannabis might help those with Florida qualifying conditions : Florida Cancer Patients : Patients say that it benefits them in several ways: by quelling nausea, suppressing vomiting resulting from chemotherapy, increasing appetite, alleviating pain, and soothing anxiety.

Conditions 52

Conditions Nerve Pain Marijuana Epilepsy 52

Cannabis Law Report

AUGUST 5, 2019

France is searching for patients to take part in an official medical cannabis trial, but users will not be smoking the drug. Patients with muscle spasms related to multiple sclerosis are also invited to take part. If you wish to re-publish this story please do so with following accreditation. AUTHOR: Mark Taylor.

Medicine 60

Medicine Patients Digestion Epilepsy 60

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. TSC is typically diagnosed in childhood. (5)

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Veriheal

NOVEMBER 18, 2022

Texas’ medical cannabis program is in the midst of a massive spike in patient registrations. According to the Texas Department of Public Safety Chief Wayne Muller, the state has averaged a 10% month-over-month increase in medical cannabis patients over the last 18 months. Texas’ Medical Cannabis Program Sees Growth Despite Limitations.

Edibles 98

Edibles Hemp Epilepsy Programs 98

TheAnswerPage

JULY 17, 2022

In 2017, researchers performed an analysis of observational clinical studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products. Two thirds of patients reported improvement in the frequency of seizures (399/622, 64%). Are CBD-rich extracts more effective at reducing seizures compared to purified CBD products?

Epilepsy 72

Epilepsy Extraction Treatment CBD 72

Cannabis Law Report

JUNE 5, 2019

The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Today (30 May) at 09.30 Sick group 1.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

TheAnswerPage

JULY 19, 2022

Have researchers found that patients who use cannabidiol (CBD)-rich extract therapy for the treatment of epilepsy require a lower dose of CBD medication as compared to those who use purified CBD therapy for the treatment of epilepsy? Pamplona F, da Silva L and Coan A. 12 September 2018. Sec.Neuropharmacology. See the Answer.

Epilepsy 52

Epilepsy Therapy Extraction Data 52

MedicalJane

JUNE 12, 2020

Of the 1,276 participants, 524 adult patients and 284 adult caregivers of children or dependent adults, all self-reported using cannabis for medicinal purposes. The control group consisted of 271 adult patients who were considering cannabis use, and 197 adult caregivers who were considering it for a dependent child or adult patient.

Chronic Pain 145

Chronic Pain Epilepsy Patients Medicine 145

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

TheAnswerPage

JULY 18, 2022

Do patients report more side effects from cannabidiol (CBD)-rich extract therapy or from purified CBD therapy? Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis Front. Pamplona F, da Silva L and Coan A. 12 September 2018.

Epilepsy 52

Epilepsy Therapy Extraction Treatment 52

Cannabis Law Report

JULY 24, 2019

Our clinics are based on the premise that patients are treated by our world-renowned specialists in the relevant condition. We have the expertise to prescribe medicinal cannabis in a way that fits in with other more conventional treatments as and when we judge that to be in the best interest of the patients.

Epilepsy 40

Epilepsy Medicine Treatment Patients 40

The Joint Blog

MARCH 16, 2020

According to a new study published in the journal Phytotherapy Research, the sustained use of marijuana in patients with chronic conditions is associated with quality of life maintenance and a lack of cognitive decline. Around 90% of participants self-medicated with cannabis daily. Participants were followed-up at baseline, 4, 8 and 12?

Patients 49

Patients Marijuana Epilepsy Treatment 49

Project CBD

MARCH 21, 2023

The CBD she took may or may not have helped, but according to a recent survey of tinnitus patients, she wasn’t alone in trying — or at least in being interested in cannabis as a potential remedy. But many more patients were willing to try, perhaps as an indication of the intractability of chronic tinnitus. And its conclusion?

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

MassRoots

MARCH 5, 2019

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.

THC 111

THC CBD Data Cannabinoids 111

Cannabis Law Report

DECEMBER 1, 2019

A young girl with a drug-resistant form of epilepsy is believed to be the first and only patient in Singapore who has been given approval to use cannabis-derived medication. The move follows approvals by lawmakers in the United States to use the medication to treat rare kinds of childhood epilepsy in that country.

Epilepsy 59

Epilepsy Cannabinoids Therapy Treatment 59

The Joint Blog

JULY 17, 2020

According to a new study published in the journal Seminars in Pediatric Neurology, marijuana-based products are associated with improvements in the symptoms of autistic patients who have self-injurious behaviors and co-morbid epilepsy. Those diagnosed with both ASD and epilepsy saw a 91% seizure control improvement.

Epilepsy 47

Epilepsy Research and Development Marijuana Treatment 47

Cannabis Law Report

JANUARY 16, 2022

Some conditions for which cannabis-based treatment has been advocated include epilepsy, neuropathic pain and chronic widespread pain as well as appetite problems, nausea and vomiting and pain in cancer patients. This means Malaysia currently has no registered marijuana-based treatment.

Research and Development 98

Research and Development Pharmaceutical Epilepsy Medicine 98

Cannabis Law Report

AUGUST 17, 2021

reduction in 28-day seizure frequency relative to baseline in tuberous sclerosis complex (TSC) patients (n=23). reduction was observed in focal seizures (n=19), the most common seizure type in TSC patients. Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. Data Highlights.

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

DECEMBER 7, 2021

This trend is also observed in the pediatric population, where MCs are authorized in children for refractory epilepsy, especially in Dravet syndrome and Lennox-Gastaut syndrome 2. A systematic review published in 2017 aimed to identify available data about the therapeutic effect of cannabinoids treatment in children and adolescents.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

JULY 25, 2022

Medical marijuana is legal in Pennsylvania but it can be accessed only by registered patients with a medical marijuana card. If you do hold a medical marijuana card, you will be allowed to legally purchase up to a 30-day supply of the medicine per patient. Getting a Medical Marijuana Card in Pennsylvania. Anxiety disorders. HIV / AIDS.

Legalization 52

Legalization Marijuana Epilepsy Sativa 52

Veriheal

AUGUST 31, 2020

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Essay: “Can Cannabis Improve Patient Experience Post-Surgery?” . Vaibhav Duggal . School: Texas A&M University .

Research and Development 117

Research and Development Education Agriculture Patients 117

SpeedWeed

SEPTEMBER 15, 2021

A study from the IQVIA Institute for Human Data Science found that the number of mammograms declined 87 percent compared to the same period a year earlier. . Patients can call (480) 967-3767 to pre-register for a screening. At the event, breast cancer patients and survivors hung a string of bras across the dispensary parking lot.

Dispensary 84

Dispensary Collective Events Epilepsy 84

Veriheal

APRIL 11, 2022

You don’t take that opium poppy and ask a patient to rub it on their lip for morphine. We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Canna Care Docs

DECEMBER 16, 2020

The difference is that medical patients may have access to higher dosages, among other benefits depending on their state, and receive a higher level of service to match them with the best products for their symptoms. Nausea and vomiting. Multiple sclerosis. Psychiatric disorders like depression, anxiety, and PTSD.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

The Cannigma

MARCH 14, 2023

And the truth was that many of the early medical cannabis patients were severely ill. Cancer, HIV, epilepsy and other serious conditions were the first accepted uses of cannabis in the United States. However, since these reasons were not considered qualifying conditions in their state, they did not view that use as medical in nature.

Policy 96

Policy Research and Development Conditions Consumption 96

Cannabis Law Report

AUGUST 24, 2019

The report reveals… MGC Pharmaceuticals is set to kick off a controlled trial to discover if its medical cannabis product for the treatment of drug-resistant epilepsy has any impact on driving performance.

Epilepsy 45

Epilepsy Pharmaceutical Data Safety 45

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

The Joint Blog

DECEMBER 9, 2019

The twice-daily administration of plant-derived CBD-dominant extracts is associated with symptom improvement in adolescents with autism spectrum disorder (ASD), according to observational data published in the journal Frontiers in Neurology.

CBD 49

CBD Extraction Epilepsy Sativa 49

The Cannigma

JUNE 15, 2021

Some healthcare professionals are already encouraged by what is known, much of it anecdotal accounts from patients in their practices. The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Veriheal

FEBRUARY 10, 2022

Medical cannabis patient enrollment is on the rise in South Dakota, and what better way to stay on top of things than by introducing a cloud-based platform? For the year 2022, patients who are interested in registering for South Dakota’s medical cannabis industry can apply with ease via the new fully digital internet-based program.

Programs 52

Programs Chronic Pain Patients Conditions 52

CannaTech

AUGUST 9, 2018

We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.

Strains 69

Strains Epilepsy Advocacy Medicine 69

CannaTech

SEPTEMBER 16, 2018

Doctors have remained integral parts of a patient’s cannabis journey through what is known as the Access to Cannabis for Medical Purposes Regulation (ACMPR) act. These guidelines outline a list of qualifying conditions that patients must possess in order to legally obtain medical cannabis. Shedding Stigma and Promoting Patient Access.

Education 66

Education Medicine Clinical Trials Patients 66

The Cannigma

OCTOBER 21, 2021

As per usual, more data is needed. Epilepsy is the most obvious example, where the ketogenic diet has been applied for 100 years, cannabis has long been treated as is now also an FDA-approved treatment for a number of seizure disorders. The keto-canna connection: what do keto and cannabis have in common?

Cannabinoids 143

Cannabinoids Edibles Conditions Data 143

Veriheal

MARCH 23, 2023

Aside from Japan legalizing medical marijuana and forging a legal pathway that enables patients to use drugs made from cannabis plants, the amended legal law also seeks to criminalize the use of marijuana. Data suggests that the market has inflated from JPY4 billion (USD$3 billion) in 2019 to JPY17 billion (USD$13 billion) in 2022.

Legalization 68

Legalization Marijuana Clinical Trials Seed-To-Sale 68

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. A 2019 study found that 76% of patients in the U.S. fill an opioid prescription after having surgery compared to just 11% of Swedish patients.

Programs 52

Programs Chronic Pain Treatment Conditions 52